Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy
- 31 May 1990
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (5) , 747-750
- https://doi.org/10.1016/s0022-3476(05)82665-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Long-acting somatostatin analog in refractory neonatal hypoglycemia: Follow-up informationThe Journal of Pediatrics, 1988
- Somatostatin analogue in short term management of hyperinsulinism.Archives of Disease in Childhood, 1988
- Long‐term Use of Somatostatin Analogue SMS 201–995 in the Treatment of Hypoglycaemia Due to NesidioblastosisActa Paediatrica, 1988
- Somatostatin secretion in cultured human islet cells from patients with nesidioblastosis: A compensatory mechanism?Journal of Pediatric Surgery, 1987
- Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analogThe Journal of Pediatrics, 1987
- Long-Term Treatment of an Infant with Nesidioblastosis Using a Somatostatin AnalogueNew England Journal of Medicine, 1987
- Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starchThe Journal of Pediatrics, 1986
- Pancreatic Cholera Syndrome: Effect of a Synthetic Somatostatin Analog on Intestinal Water and Ion TransportAnnals of Internal Medicine, 1985
- Experience with 95% Pancreatectomy and Splenic Salvage for Neonatal NesidioblastosisAnnals of Surgery, 1984
- Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.Archives of Disease in Childhood, 1981